Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation

Hellwig, Malte; Merk, Daniel J.; Lutz, Beat; Schueller, Ulrich

dc.contributor.author	Merk, Daniel J.
dc.date.accessioned	2020-09-16T13:32:11Z
dc.date.available	2020-09-16T13:32:11Z
dc.date.issued	2020
dc.identifier.issn	1476-5500
dc.identifier.uri	http://hdl.handle.net/10900/106909
dc.language.iso	en	en
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41417-019-0099-5
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation	de_DE
dc.type	Article	de_DE
utue.quellen.id	20200715072417_00614
utue.publikation.seiten	294-300	de_DE
utue.personen.roh	Hellwig, Malte
utue.personen.roh	Merk, Daniel J.
utue.personen.roh	Lutz, Beat
utue.personen.roh	Schueller, Ulrich
dcterms.isPartOf.ZSTitelID	Cancer Gene Therapy	de_DE
dcterms.isPartOf.ZS-Issue	5	de_DE
dcterms.isPartOf.ZS-Volume	27	de_DE
utue.fakultaet	04 Medizinische Fakultät